- Home
- CYRX vs JBGS Comparison
CYRX vs JBGS Comparison
Compare CYRX & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | JBGS |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 774.7M | 823.7M |
| IPO Year | 2008 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CYRX | JBGS |
|---|---|---|
| Price | $15.37 | $14.15 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 1 |
| Target Price | $13.31 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 655.5K | 490.3K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $176,177,000.00 | ★ $498,598,000.00 |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.69 | $13.71 |
| 52 Week High | $16.89 | $24.30 |
Technical Indicators
Market Signals| Indicator | CYRX | JBGS |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 48.35 |
| Support Level | $14.54 | $14.13 |
| Resistance Level | $16.76 | $15.31 |
| Average True Range (ATR) | 0.81 | 0.35 |
| MACD | -0.19 | -0.03 |
| Stochastic Oscillator | 13.66 | 28.47 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.